A citation-based method for searching scientific literature

Jee Hee Yoo, Min Sun Choi, Jiyeon Ahn, Sung Woon Park, Yejin Kim, Kyu Yeon Hur, Sang-Man Jin, Gyuri Kim, Jae Hyeon Kim. Diabetes Technol Ther 2020
Times Cited: 17







List of co-cited articles
107 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.
Tadej Battelino, Thomas Danne, Richard M Bergenstal, Stephanie A Amiel, Roy Beck, Torben Biester, Emanuele Bosi, Bruce A Buckingham, William T Cefalu, Kelly L Close,[...]. Diabetes Care 2019
604
94

Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes.
Jingyi Lu, Xiaojing Ma, Jian Zhou, Lei Zhang, Yifei Mo, Lingwen Ying, Wei Lu, Wei Zhu, Yuqian Bao, Robert A Vigersky,[...]. Diabetes Care 2018
140
82

Time in Range Is Associated with Carotid Intima-Media Thickness in Type 2 Diabetes.
Jingyi Lu, Xiaojing Ma, Yun Shen, Qiang Wu, Ren Wang, Lei Zhang, Yifei Mo, Wei Lu, Wei Zhu, Yuqian Bao,[...]. Diabetes Technol Ther 2020
47
76

Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials.
Roy W Beck, Richard M Bergenstal, Tonya D Riddlesworth, Craig Kollman, Zhaomian Li, Adam S Brown, Kelly L Close. Diabetes Care 2019
199
64

The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes.
Robert A Vigersky, Chantal McMahon. Diabetes Technol Ther 2019
109
64

International Consensus on Use of Continuous Glucose Monitoring.
Thomas Danne, Revital Nimri, Tadej Battelino, Richard M Bergenstal, Kelly L Close, J Hans DeVries, Satish Garg, Lutz Heinemann, Irl Hirsch, Stephanie A Amiel,[...]. Diabetes Care 2017
589
52

Glucose time in range and peripheral neuropathy in type 2 diabetes mellitus and chronic kidney disease.
Laura Mayeda, Ronit Katz, Iram Ahmad, Nisha Bansal, Zona Batacchi, Irl B Hirsch, Nicole Robinson, Dace L Trence, Leila Zelnick, Ian H de Boer. BMJ Open Diabetes Res Care 2020
21
52

The Relationships Between Time in Range, Hyperglycemia Metrics, and HbA1c.
Roy W Beck, Richard M Bergenstal, Peiyao Cheng, Craig Kollman, Anders L Carlson, Mary L Johnson, David Rodbard. J Diabetes Sci Technol 2019
109
52


Time in Range, as a Novel Metric of Glycemic Control, Is Reversely Associated with Presence of Diabetic Cardiovascular Autonomic Neuropathy Independent of HbA1c in Chinese Type 2 Diabetes.
Qingyu Guo, Pu Zang, Shaoying Xu, Wenjing Song, Zhen Zhang, Chunyan Liu, Zhanhong Guo, Jing Chen, Bin Lu, Ping Gu,[...]. J Diabetes Res 2020
19
41

Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring.
Richard M Bergenstal, Roy W Beck, Kelly L Close, George Grunberger, David B Sacks, Aaron Kowalski, Adam S Brown, Lutz Heinemann, Grazia Aleppo, Donna B Ryan,[...]. Diabetes Care 2018
144
41

The Fallacy of Average: How Using HbA1c Alone to Assess Glycemic Control Can Be Misleading.
Roy W Beck, Crystal G Connor, Deborah M Mullen, David M Wesley, Richard M Bergenstal. Diabetes Care 2017
139
41




Optimal Sampling Duration for Continuous Glucose Monitoring to Determine Long-Term Glycemic Control.
Tonya D Riddlesworth, Roy W Beck, Robin L Gal, Crystal G Connor, Richard M Bergenstal, Sooji Lee, Steven M Willi. Diabetes Technol Ther 2018
75
35

Optimal sampling intervals to assess long-term glycemic control using continuous glucose monitoring.
Dongyuan Xing, Craig Kollman, Roy W Beck, William V Tamborlane, Lori Laffel, Bruce A Buckingham, Darrell M Wilson, Stuart Weinzimer, Rosanna Fiallo-Scharer, Katrina J Ruedy. Diabetes Technol Ther 2011
55
29

Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
Roy W Beck, Tonya Riddlesworth, Katrina Ruedy, Andrew Ahmann, Richard Bergenstal, Stacie Haller, Craig Kollman, Davida Kruger, Janet B McGill, William Polonsky,[...]. JAMA 2017
404
29

Toward Defining the Threshold Between Low and High Glucose Variability in Diabetes.
Louis Monnier, Claude Colette, Anne Wojtusciszyn, Sylvie Dejager, Eric Renard, Nicolas Molinari, David R Owens. Diabetes Care 2017
128
29

Effects of intensive glucose lowering in type 2 diabetes.
Hertzel C Gerstein, Michael E Miller, Robert P Byington, David C Goff, J Thomas Bigger, John B Buse, William C Cushman, Saul Genuth, Faramarz Ismail-Beigi, Richard H Grimm,[...]. N Engl J Med 2008
23

Glucose control and vascular complications in veterans with type 2 diabetes.
William Duckworth, Carlos Abraira, Thomas Moritz, Domenic Reda, Nicholas Emanuele, Peter D Reaven, Franklin J Zieve, Jennifer Marks, Stephen N Davis, Rodney Hayward,[...]. N Engl J Med 2009
23

Does Time-in-Range Matter? Perspectives From People With Diabetes on the Success of Current Therapies and the Drivers of Improved Outcomes.
Ava S Runge, Lynn Kennedy, Adam S Brown, Abigail E Dove, Brian J Levine, Sophie P Koontz, Varun S Iyengar, Sarah A Odeh, Kelly L Close, Irl B Hirsch,[...]. Clin Diabetes 2018
40
23

Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections: A Randomized Trial.
Roy W Beck, Tonya D Riddlesworth, Katrina Ruedy, Andrew Ahmann, Stacie Haller, Davida Kruger, Janet B McGill, William Polonsky, David Price, Stephen Aronoff,[...]. Ann Intern Med 2017
158
23


Improved Time in Range Over 1 Year Is Associated With Reduced Albuminuria in Individuals With Sensor-Augmented Insulin Pump-Treated Type 1 Diabetes.
Ajenthen G Ranjan, Signe V Rosenlund, Tine W Hansen, Peter Rossing, Steen Andersen, Kirsten Nørgaard. Diabetes Care 2020
10
40

Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP).
Richard M Bergenstal, Andrew J Ahmann, Timothy Bailey, Roy W Beck, Joan Bissen, Bruce Buckingham, Larry Deeb, Robert H Dolin, Satish K Garg, Robin Goland,[...]. Diabetes Technol Ther 2013
148
23


Respective Contributions of Glycemic Variability and Mean Daily Glucose as Predictors of Hypoglycemia in Type 1 Diabetes: Are They Equivalent?
Louis Monnier, Anne Wojtusciszyn, Nicolas Molinari, Claude Colette, Eric Renard, David Owens. Diabetes Care 2020
14
28

Time in Range in Relation to All-Cause and Cardiovascular Mortality in Patients With Type 2 Diabetes: A Prospective Cohort Study.
Jingyi Lu, Chunfang Wang, Yun Shen, Lei Chen, Lei Zhang, Jinghao Cai, Wei Lu, Wei Zhu, Gang Hu, Tian Xia,[...]. Diabetes Care 2021
16
25

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
Anushka Patel, Stephen MacMahon, John Chalmers, Bruce Neal, Laurent Billot, Mark Woodward, Michel Marre, Mark Cooper, Paul Glasziou, Diederick Grobbee,[...]. N Engl J Med 2008
17

The association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes.
Ji Eun Jun, Sang-Man Jin, Jongha Baek, Sewon Oh, Kyu Yeon Hur, Myung-Shik Lee, Moon-Kyu Lee, Jae Hyeon Kim. Cardiovasc Diabetol 2015
56
17

Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.
David M Nathan, Patricia A Cleary, Jye-Yu C Backlund, Saul M Genuth, John M Lachin, Trevor J Orchard, Philip Raskin, Bernard Zinman. N Engl J Med 2005
17

Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial.
Richard E Pratley, Lauren G Kanapka, Michael R Rickels, Andrew Ahmann, Grazia Aleppo, Roy Beck, Anuj Bhargava, Bruce W Bode, Anders Carlson, Naomi S Chaytor,[...]. JAMA 2020
24
17



Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial.
Jan Bolinder, Ramiro Antuna, Petronella Geelhoed-Duijvestijn, Jens Kröger, Raimund Weitgasser. Lancet 2016
359
17

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.
I M Stratton, A I Adler, H A Neil, D R Matthews, S E Manley, C A Cull, D Hadden, R C Turner, R R Holman. BMJ 2000
17

Threshold-based insulin-pump interruption for reduction of hypoglycemia.
Richard M Bergenstal, David C Klonoff, Satish K Garg, Bruce W Bode, Melissa Meredith, Robert H Slover, Andrew J Ahmann, John B Welsh, Scott W Lee, Francine R Kaufman. N Engl J Med 2013
380
17

Estimation of Hemoglobin A1c from Continuous Glucose Monitoring Data in Individuals with Type 1 Diabetes: Is Time In Range All We Need?
Chiara Fabris, Lutz Heinemann, Roy Beck, Claudio Cobelli, Boris Kovatchev. Diabetes Technol Ther 2020
13
23



Connecting the Dots: Validation of Time in Range Metrics With Microvascular Outcomes.
Irl B Hirsch, Jennifer L Sherr, Korey K Hood. Diabetes Care 2019
22
17

Metrics Beyond Hemoglobin A1C in Diabetes Management: Time in Range, Hypoglycemia, and Other Parameters.
Lorena Alarcon-Casas Wright, Irl B Hirsch. Diabetes Technol Ther 2017
71
17

HbA1c: The Glucose Management Indicator, Time in Range, and Standardization of Continuous Glucose Monitoring Reports in Clinical Practice.
Anders L Carlson, Amy B Criego, Thomas W Martens, Richard M Bergenstal. Endocrinol Metab Clin North Am 2020
10
30

Utilizing the Ambulatory Glucose Profile to Standardize and Implement Continuous Glucose Monitoring in Clinical Practice.
Mary L Johnson, Thomas W Martens, Amy B Criego, Anders L Carlson, Gregg D Simonson, Richard M Bergenstal. Diabetes Technol Ther 2019
28
17

Associations between HbA1c and continuous glucose monitoring-derived glycaemic variables.
I B Hirsch, J B Welsh, P Calhoun, S Puhr, T C Walker, D A Price. Diabet Med 2019
19
17

Glycemic Outcomes in Adults With T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 Years of Follow-Up From the COMISAIR Study.
Jan Šoupal, Lenka Petruželková, George Grunberger, Aneta Hásková, Milan Flekač, Martin Matoulek, Ondřej Mikeš, Tomáš Pelcl, Jan Škrha, Eva Horová,[...]. Diabetes Care 2020
50
17



Association between the extent of urinary albumin excretion and glycaemic variability indices measured by continuous glucose monitoring.
S-M Jin, T-H Kim, S Oh, J Baek, J Y Joung, S-M Park, Y Y Cho, S Y Sohn, K Y Hur, M-S Lee,[...]. Diabet Med 2015
17
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.